the invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease
This data helps distinguish medication side effects from IBD flares during GLP-1 titration and informs dose escalation decisions
No evidence this occurs but cautious approach warranted
This discipline reduces variability and makes published results more reproducible a recurring theme in peer review of peptide studies and a small but important contributor to data quality